0000899243-16-032475.txt : 20161031
0000899243-16-032475.hdr.sgml : 20161031
20161031160717
ACCESSION NUMBER: 0000899243-16-032475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161028
FILED AS OF DATE: 20161031
DATE AS OF CHANGE: 20161031
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-466-3500
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holmes Scott A
CENTRAL INDEX KEY: 0001537670
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 161961705
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS INC
STREET 2: 1 MARINA PARK DR., 10TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-10-28
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001537670
Holmes Scott A
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
0
1
0
0
Chief Financial Officer
Common Stock
2016-10-28
4
S
0
1237
4.44
D
107320
D
Sale of a total of 1,237 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 3,750 shares of restricted stock on October 27, 2016. Mr. Holmes had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Includes 79,999 shares of restricted stock.
/s/ Brian Adams, Attorney-in-Fact
2016-10-31